Recent Publications
Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer.
Leapman MS, Rothen J, Long JB, Kim IE, Mitchell AE, Yu JB, Dinan MA, Gross CP, Ma X
JAMA Oncol. 2026 May 7; doi: 10.1001/jamaoncol.2026.0893. Epub 2026 May 7.
PMID: 42096231
County-Level Structural Racism Indices and Racial Disparities in Lung Cancer Care.
Gaddy JJ, Lee DH, Herrin J, Yu JB, Pollack CE, Dean LT, Dougherty GB, Canavan ME, Soulos PR, Gross CP
JAMA Netw Open. 2026 May 1;9(5):e2613919. doi: 10.1001/jamanetworkopen.2026.13919. Epub 2026 May 1.
PMID: 42160049
In Reply to Shaffer et al.
Yu JB, Grew D, Spraker MB, Beckta JM, Shah C, Brower JV
Pract Radiat Oncol. 2026 May-Jun;16(3):320. doi: 10.1016/j.prro.2025.10.016.
PMID: 42103411
Factors Associated With Rectal Spacer Use in Prostate Cancer Patients Receiving Radiation Therapy.
Hankins RA, Morris KC, McGovern AM, Zack J, Collins SP, Yu JB
Cancer Med. 2026 May;15(5):e71765. doi: 10.1002/cam4.71765.
PMID: 42046879
Treatment-Free Survival: A Novel Endpoint in Trials of Stereotactic Body Radiation With or Without Systemic Therapy.
Einstein DJ, Chen RC, Hoffman KE, Madan RA, Marvaso G, Tang C, Tran PT, Yu JB, Regan MM
Int J Radiat Oncol Biol Phys. 2026 May 1;125(1):40-43. doi: 10.1016/j.ijrobp.2025.11.006.
PMID: 42000365
The Comparative Toxicity of Focal Ablation Versus Intensity Modulated Radiation Therapy for Prostate Cancer.
Yu JB, DeStephano DM, Jeffers B, Tward AE, Spina CS, Horowitz DP, Wang TJC, Kachnic LA, Soulos PR, Gross CP, Cheng SK
Int J Radiat Oncol Biol Phys. 2026 Mar 15;124(4):937-948. doi: 10.1016/j.ijrobp.2025.09.020. Epub 2025 Sep 23.
PMID: 40998272
Early-Stage Lung Cancer Treatment Disparities by Race Among Medicare Beneficiaries.
Lynch OF, Lee DH, Soulos PR, Yu JB, Herrin J, Gross CP
JAMA Netw Open. 2026 Mar 2;9(3):e2559845. doi: 10.1001/jamanetworkopen.2025.59845. Epub 2026 Mar 2.
PMID: 41770564
Association between rectal spacer use and bowel, urinary, and sexual dysfunction following prostate cancer brachytherapy: U.S. claims data analysis.
Folkert MR, Weg ES, Sato R, Yu JB, Bhattacharyya S, Ezekekwu E, Hamstra DA
Brachytherapy. 2026 Mar-Apr;25(2):402-409. doi: 10.1016/j.brachy.2025.10.015. Epub 2025 Dec 14.
PMID: 41392003
Integrating Locoregional Therapies Into Oncology Value Frameworks to Improve Patient-Centered Decision-Making and Outcomes.
Asare KB, Corn BW, Ennis RD, Sapir E, Kapadia N, Gross CP, Yu JB
Pract Radiat Oncol. 2026 Feb 28; pii: S1879-8500(26)00062-7. doi: 10.1016/j.prro.2026.02.009. Epub 2026 Feb 28.
PMID: 41771435
FORMULA-509: A Multicenter Randomized Trial of Postprostatectomy Salvage Radiotherapy and 6 months of a GNRH Agonist with Either Bicalutamide or Abiraterone Acetate plus Prednisone and Apalutamide.
Nguyen PL, Kollmeier MA, Rathkopf DE, Hoffman KE, Zurita AJ, Spratt DE, Dess RT, Liauw SL, Szmulewitz RZ, Einstein DJ, Bubley GJ, Yu JB, An Y, Wong AC, Feng FY, McKay RR, Rose BS, Shin KY, Kibel AS, Taplin ME
Eur Urol. 2026 Feb 10; pii: S0302-2838(25)04854-7. doi: 10.1016/j.eururo.2025.12.001. Epub 2026 Feb 10.
PMID: 41672869